4Remme W j, Kruyssen HA, et al.Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventrieular function. Am Heart J,1991,122(1):96.
5Vietti RG,Veglio F,Marchisio U,et al.Efficacy and safety of short intravenous amiodarone in supra-ventrictlar tachyarrhythmias.Int J Cardiol,1992,35(1):77.
6Singh S,Fletcher R,et al.For the survival trial of antiarrhythmic therapy in congestive heart failure.Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia.N Engl J Med,1995,333(1):77.
7Khosal S, Duggal C, et al.Successful heart failure therapy is effeetive antiarrhythmia therapy.Am Heart J,1996,131(4):1048.
8Peter C, Nalos MD, Yahya MD, et al. Intravenous amiodarone for shortterm treatment of refractory ventricular taehyeardia or fibrillation.Am Heart J, 1991,122(5):1629.
9Myerburg RJ,Mitrani R, Interian JRA, et al. Evaluation of pharma-cological and device therapy for the management of life-threatening arrhythmias.Eur Heart J Supplements,1999,1(suppl C):21.
10Connolly SJ. Prophylactic antiarrhythmic therapy for the prevention of sudden death in high-risk patients: drugs and devices. Eur Heart J Supplements,1999, 1(suppl C):31.
